AllSight
Companies · SIBN · Surgical & Medical Instruments & Apparatus

SI-BONE, Inc. (SIBN)

SI-BONE, Inc. (SIBN) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

SI-BONE, Inc. (SIBN) stock — financials & valuation

Key numbers for SI-BONE, Inc. (SIBN): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 46/100 — a percentile rank of SI-BONE, Inc.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.

Market cap$825.1M
P / S3.9×
EV / EBITDA-69.2×
Gross margin79.5%
Operating margin-8.3%
Net margin-6.9%
Return on equity-8.0%
ROIC-9.6%
Revenue growth15.3%
Debt / equity0.2×
Dividend yield0.0%

Is SI-BONE, Inc. overvalued? P/S looks fair vs its 5-year range; P/B looks fair vs its 5-year range.

Independent of the events above — derived from SI-BONE, Inc.’s own financial statements and shown as context, never as advice.

Sep 11, 202698-implant recall
SI-BONE recalls 98 implants over sterile-barrier failure; $150K charge estimated
Related companies in Surgical & Medical Instruments & Apparatus
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact